Table 5.
Antigen | Primers 5’ – 3’ Forward Reverse |
Predicted length of amplicona (%) | Lengths of readable sequence | Total no. sequences obtained | Total no. SNP locationsb | Total no. allelesc,d | Total no. non-synonymous SNP locations | Total no. protein variantsc,d | Total no. epitope variants |
---|---|---|---|---|---|---|---|---|---|
Tp1 | ATGGCCACTTCAATTGCATTTGCC GAAGCTCATAAATATTTCATT |
387 (22) | 363–399 | 11 | 19 | 8 | 16 | 8 | 2 |
Tp2 | ATGAAATTGGCCGCCAGATTA GAAGCCTCCGGCACTTCATAG |
483 (47) | 456–480 | 9 | 220 | 7 | 92 | 7 | See Table 2 |
Tp3 | ATGAAATTAAATACTATCGCAATAG ACCTTCACTAAGAGTCCAGACGATAAT |
735 (89) | 686–726 | 24 | 26 | 13 | 12 | 9 | n/a |
Tp4 | CCAATTGGTGATTTAGCAACA CTCCGTAAATCATGTTAATGGAGT |
692 (27) | 386–422 | 24 | 36 | 13 | 5 | 6 | 1 |
Tp5 | ATGAGGAAGCGAGTTTGGG CGATATCGATGATTTATAA |
238 (31) | 200–238 | 16 | 26 | 6 | 3 | 3 | 1 |
Tp6 | ATGGCTCAGATTCCTGTTG CTCTTACTCTCAACTGATAAATAA |
1005 (92) | 569–833 | 23 | 23 | 13 | 1 | 2 | n/a |
Tp7 | ATGGAGGCACTGCAAGCAGGC GTCACTGACGAGGAGGAGAAAAAG |
417 (14) | 299–332 | 25 | 33 | 9 | 4 | 3 | 1 |
Tp8 | ATGCTTGGAAATCATGTCATGGGA CTCCTTCGCAGTGTACGCAGTTTAA | 1275 (81) | 931–1109 | 22 | 19 | 12 | 6 | 7 | 1 |
Tp9 | ATGAATGTTCTAACTACTGG CGTAATAAACCATGGACAAAACAATAA |
958 (95) | 326–1057 | 37 | >100 | 28 | >100 | 27 | 12 |
Tp10 | GACTACGCTCTTCTTACCAC CCATCCAGGAGTGTAATGCC |
916 (89) | 505–824 | 22 | 24 | 13 | 7 | 6 | n/a |
The sequence length of the predicted amplicon from the reference sequence, excluding primers, is shown. The figures in brackets represent the length of the amplicon as a percentage of the length of the coding sequence from the reference gene, including introns.
SNPs within introns are not included.
Alleles or protein variants which have ambiguous residues (labelled X.1 in Table 1) are not included, unless they are unique, validated variants.
Unique, validated alleles or protein variants obtained from partial sequences are included if the constitute a variant.